Adalimumab for hidradenitis suppurativa

Affiliations

¹ Loma Linda University, School of Medicine, California, USA.
² University of California, Riverside School of Medicine, USA.
³ Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, California, USA.

Comment

Daniel J No et al. Cutis. 2017 Aug.

. 2017 Aug;100(2):100.

¹ Loma Linda University, School of Medicine, California, USA.
² University of California, Riverside School of Medicine, USA.
³ Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, California, USA.

No abstract available

Comment on

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.
Kimball AB, Okun MM, Williams DA, Gottlieb AB, Papp KA, Zouboulis CC, Armstrong AW, Kerdel F, Gold MH, Forman SB, Korman NJ, Giamarellos-Bourboulis EJ, Crowley JJ, Lynde C, Reguiai Z, Prens EP, Alwawi E, Mostafa NM, Pinsky B, Sundaram M, Gu Y, Carlson DM, Jemec GB. Kimball AB, et al. N Engl J Med. 2016 Aug 4;375(5):422-34. doi: 10.1056/NEJMoa1504370. N Engl J Med. 2016. PMID: 27518661 Clinical Trial.